Analyst Price Target is $3.50
▲ +44.63% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for ReWalk Robotics in the last 3 months. The average price target is $3.50, with a high forecast of $3.50 and a low forecast of $3.50. The average price target represents a 44.63% upside from the last price of $2.42.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in ReWalk Robotics. This Buy consensus rating has held steady for over two years.
ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.